Solventum Reports Strong Q4 2025 Results, Projects Significant 2026 EPS and Free Cash Flow Growth

summarizeSummary

The filing details Solventum's fourth-quarter 2025 performance, which included 3.5% organic sales growth and adjusted diluted EPS of $1.57. While full-year 2025 adjusted EPS saw a decline and free cash flow was negative, the company's 2026 guidance is notably positive. Management projects organic sales growth of 2.0% to 3.0%, adjusted EPS of $6.40 to $6.60 (an increase from 2025's $6.11), and a significant recovery in free cash flow to approximately $200 million from a negative $10 million in 2025. This forward-looking guidance, particularly the strong free cash flow rebound, signals improved operational efficiency and financial health, which is a key positive for investors.

check_boxKey Events

• Q4 2025 Performance Exceeds Expectations

  Reported $2 billion in sales with 3.5% organic growth and adjusted diluted EPS of $1.57, with management stating full-year 2025 results were ahead of expectations.

• Full-Year 2026 Adjusted EPS Guidance

  Projected adjusted diluted EPS of $6.40 to $6.60, indicating growth from the $6.11 reported for full-year 2025.

• Significant Free Cash Flow Recovery Projected for 2026

  Guidance for full-year 2026 free cash flow is approximately $200 million, a substantial improvement from the negative $10 million reported for full-year 2025.

• Organic Sales Growth Outlook

  Forecasts full-year 2026 organic sales growth of +2.0% to +3.0%.

auto_awesomeAnalysis

The filing details Solventum's fourth-quarter 2025 performance, which included 3.5% organic sales growth and adjusted diluted EPS of $1.57. While full-year 2025 adjusted EPS saw a decline and free cash flow was negative, the company's 2026 guidance is notably positive. Management projects organic sales growth of 2.0% to 3.0%, adjusted EPS of $6.40 to $6.60 (an increase from 2025's $6.11), and a significant recovery in free cash flow to approximately $200 million from a negative $10 million in 2025. This forward-looking guidance, particularly the strong free cash flow rebound, signals improved operational efficiency and financial health, which is a key positive for investors.